Effects of estrogen replacement therapy on the lipoprotein profile in postmenopausal women with ESRD
- 1 October 1998
- journal article
- clinical trial
- Published by Elsevier in Kidney International
- Vol. 54 (4) , 1344-1350
- https://doi.org/10.1046/j.1523-1755.1998.00087.x
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Estrogen replacement therapy and coagulation: Relationship to lipid and lipoprotein changesPublished by Wolters Kluwer Health ,1998
- Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogensThe Lancet, 1996
- Hyperlipidemia of Chronic Renal FailureBlood Purification, 1994
- Plasma Lp(a) concentration after oestrogen and progestagen in postmenopausal womenThe Lancet, 1991
- Hyperlipoproteinemia in Chronic Renal Failure: Pathophysiological and Therapeutic AspectsCardiology, 1991
- Lipoprotein (a). Heterogeneity and biological relevance.Journal of Clinical Investigation, 1990
- EFFECTS OF TREATMENT WITH OESTRADIOL/LEVONORGESTREL ON BONE, LIPOPROTEINS AND HORMONE STATUS IN POSTMENOPAUSAL WOMENClinical Endocrinology, 1989
- The Risk of Breast Cancer after Estrogen and Estrogen–Progestin ReplacementNew England Journal of Medicine, 1989
- Conjugated Estrogens for the Management of Bleeding Associated with Renal FailureNew England Journal of Medicine, 1986
- Putative atherogenic factors in patients with chronic renal failureProgress in Cardiovascular Diseases, 1983